PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 183 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $859,430,000 | -18.9% | 22,575 | -7.4% | 0.01% | -26.7% |
| Q2 2019 | $1,060,025,000 | +20.6% | 24,374 | +5.5% | 0.02% | +25.0% |
| Q1 2019 | $879,262,000 | -11.5% | 23,102 | 0.0% | 0.01% | -25.0% |
| Q4 2018 | $993,848,000 | -13.3% | 23,102 | -1.0% | 0.02% | 0.0% |
| Q3 2018 | $1,146,473,000 | +53.4% | 23,326 | 0.0% | 0.02% | +60.0% |
| Q2 2018 | $747,598,000 | +12.4% | 23,326 | +9.3% | 0.01% | +11.1% |
| Q1 2018 | $665,084,000 | -30.8% | 21,351 | +1.4% | 0.01% | -25.0% |
| Q4 2017 | $961,617,000 | +23.7% | 21,065 | +1.7% | 0.01% | +20.0% |
| Q3 2017 | $777,435,000 | +30.3% | 20,704 | +65.5% | 0.01% | +11.1% |
| Q2 2017 | $596,632,000 | – | 12,508 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |